93
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Remaining Problems and Controversies in the Management of Childhood Head and Neck Soft Tissue Sarcomas: Retrospective (National) Multicenter Study of the Polish Pediatric Solid Tumors Group

, , , , , , , , , , , , , , , , , , , , & show all
Pages 349-362 | Published online: 09 Jul 2009

REFERENCES

  • Paulino AC. Role of radiation therapy in parameningeal rhabdomyosarcoma. Cancer Invest 1999;17: 223-230.
  • Mullaney PB, Nabi NU, Thorner P, Buncic R. Ophthalmic involvement as a presenting feature of nonorbital childhood parameningeal embryonal rhabdomyosarcoma. Ophthalmology. 2001;108:179- 182.
  • Raney RB, Anderson JR, KollathJ, et al. Late effects of therapy in 94 patients with localised rhab-domyosarcoma of the orbit: report from the Intergroup Rhabdomyosarcoma Study (IRS)-III, 1984- 1991. Med Pediatr Oncol 2000;34:413-420.
  • Raney RB, Asmar L, Vassilopoulou-Sellin R, et al. Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: a descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and -III IRS Group of the Children’s Cancer Group and the Pediatric Oncology Group. Med Pediatr Oncol 1999;33:362-371.
  • Denys D, Kaste SC, Kun LE, Chaudhary MA, Bowman LC, Robbins KT. The effects of radiation on craniofacial skeletal growth: a quantitative study. Int J Pediatr Otorhinolaryngol. 1998;45: 7-13.
  • Schouwenburg PF, Kupperman D, Bakker FP, Blank L, de Boer HB, Voute TA. New combined treatment of surgery, radiotherapy, and reconstruction in head and neck rhabdomyosarcoma in children: the AMORE protocol. Head Neck. 1998;20:283-292.
  • BenkV, Rodary C, Donaldson SS, etal. Parameningeal rhabdomyosarcoma: results of an international workshop. Int JRadiat Oncol. 1996;36:533-540.
  • Multizentrische Therapiestudie zur Behandlung von Kindern und Jugendlichen mit Weichteil-sarkomen, Cooperative Wichteilsarkomstudie CWS-91, 1991, Protokoll.
  • SIOP-IV-Intergroup, 1989, protocol.
  • Multizentrische Therapiestudie zur Behandlung von Kindern und Jugendlichen mit Weichteil-sarkomen, Cooperative Wichteilsarkom Studie CWS-96, 1996, Protokoll.
  • Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc. 1958;53: 457-481.
  • Peto R, Pike MC, Armitage P, et al. Design and analysis of randomised clinical trials requiring pro-longed observation of each patient, II: analysis and examples. Br J Cancer. 1977;35:1-39.
  • Raney RB, MezaJ, Anderson JR, et al. Treatment of children and adolescents with localized para-meningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group Protocols IRS-II through-IV, 1978-1997. Med pediatr Oncol. 2002;38:22-32.
  • Oberlin O, Rey A, AndersonJ, et al. Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment-results of an international workshop. J Clin Oncol. 2001;19:197-204.
  • Shields CL, Shields JA, Honavar SG, Demirci H. Clinical spectrum of primary ophthalmic rhab-domyosarcoma. Ophthalmology. 2001;108:2284-2292.
  • Flamant F, Rodary C, Rey A, et al. Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence: results of the second study of the International Society of Paediatric Oncology: MMT84. Eur J Cancer. 1998;34:1050-1062.
  • Koscielniak E, Harms D, Henze G, et al. Results of treatment for soft tissue sarcomas in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86.JClin Oncol. 1999;17:3706-3719.
  • Choong PFM, Akerman M, Willen H, et al. Prognostic value of Ki-67 expression in 182 soft tissue sarcomas: proliferation-a marker of metastasis. APMIS. 1994;102:915-924.
  • Ueda T, Aozasa K, TsujimotoM, etal. Prognostic significance of Ki-67 reactivity in soft tissue sarcomas. Cancer. 1989;63:1607-1611.
  • Skytting BT, Bauer HC, Perfekt R, Nilsson G, Larsson O. Ki-67 is strongly prognostic in synovial sarcoma: analysis based on 86 patients from the Scandinavian Sarcoma Group Register. Br J Cancer. 1999;80:1809-1814.
  • Huuhtanen RL, Blomqvist CP, Bohling TO, et al. Expression of cyclin A in soft tissue sarcomas correlates with tumor aggressiveness. Cancer Res. 1999;59:2885-2890.
  • Huuhtanen RL, Wiklund TA, Blomqvist CP, et al. A high proliferation rate measured by cyclin A predicts a favorable chemotherapy response in soft tissue sarcoma patients. Br J Cancer. 1999;81:1017- 1021.
  • Schneider-Stock R, Rys J, Jaeger V, et al. Prognostic significance of telomerase activity in soft tissue sarcomas. Int J Oncol. 1999;15:775-780.
  • Leonard MP, Partin AW, Epstein JI, Jeffs RD, Gearhart JP. Nuclear morphometry as a prognostic indicator for genitourinary rhabdomyosarcoma: a preliminary investigation. J Urol. 1990;144:1222- 1226.
  • Noguchi S, Tamiya S, Nagoshi M, Suita S, Fukuda T, Tsuneyoshi M. Nuclear morphometry and the MIB-1 index in rhabdomyosarcoma. Mod Pathol. 1996;9:253-260.
  • Baker KS, Anderson JR, Link MP, et al. Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol. 2000;18:2427-2434.
  • Daya H, Chan HS, Sirkin W, Forte V. Pediatric rhabdomyosarcoma of the head and neck: is there a place for surgical management Arch Otolaryngol Head Neck Surg. 2000;126:468-472.
  • Tabone MD, Terrier P, Pacquement H, et al. Outcome of radiation-related osteosarcoma after treat-ment of childhood and adolescent cancer: a study of 23 cases. J Clin Oncol. 1999;17:2789-2795.
  • Michalski JM, Sur RK, Harms WB, Purdy JA. Three-dimensional conformal radiation therapy in pediatric parameningeal rhabdomyosarcomas. Int J Radiat Oncol. 1995;33:985-991.
  • Hug EB, Adams J, Fitzek M, De Vries A, Munzenrider JE. Fractionated, three-dimensional, planning-assisted proton-radiation therapy for orbital rhabdomyosarcoma: a novel technique. Int J Radiat Oncol. 2000;47:979-984.
  • Regine WF, Fontanesi J, Kumar P, et al. Local tumor control in rhabdomyosarcoma following low-dose irradiation: comparison of group II and select group III patients. Int J Radiat Oncol. 1995;31:485-491.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.